Verucerfont
目录号: A16950
CRF-1 拮抗剂
Verucerfont,也被称为 GSK561679 和 NBI77860,是一种 CRF-1 拮抗剂。Verucerfont 阻断 CRH-1 受体,从而在慢性压力后减少 ACTH 的释放。
Discription | Verucerfont, also known as GSK561679 and NBI77860, is a CRF-1 antagonist. Verucerfont blocks the CRH-1 receptor, and so reduces ACTH release following chronic stress. |
---|
目录号 | A16950 |
---|---|
分子式 | C22H26N6O2 |
分子量 | 406.49 |
CAS号 | 885220-61-1 |
SMILES | CC[C@H](NC1=CC(C)=NC2=C(C3=CC=C(OC)C=C3C)C(C)=NN12)C4=NC(C)=NO4 |
其他名称 | GSK561679, GSK-561679, GSK 561679, SK-561,679, GSK561679A, NBI77860, NBI-77860, NBI 77860 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2